New pharmacotherapy options for chemotherapy-induced alimentary mucositis

Expert Opinion on Biological Therapy

Volumn 14, Issue 3, 2014, Pages 347-354

  Wardill, Hannah R ^a   Bowen, Joanne M ^a   Gibson, Rachel J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chemotherapy; Mucositis; Pharmacotherapy; Prevention; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; EMU OIL; KERATINOCYTE GROWTH FACTOR; OIL; ZINC SULFATE;

ANIMAL; CHEMICALLY INDUCED; DIGESTIVE SYSTEM; DRUG EFFECTS; GASTROINTESTINAL TRACT; HONEY; HUMAN; INTESTINE MUCOSA; MUCOSITIS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; DIGESTIVE SYSTEM; FIBROBLAST GROWTH FACTOR 7; GASTROINTESTINAL TRACT; HONEY; HUMANS; INTESTINAL MUCOSA; MUCOSITIS; OILS; ZINC SULFATE;

EID: 84894183124     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2014.874412     Document Type: Review

References (56)

1. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol 2004;2:3-8
2. Sonis ST. A biological approach to mucositis. J Support Oncol 2004;2:21-32; discussion 5-6
3. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84.
4. Bowen JM, Elad S, Hutchins RD, Lalla RV. Methodology for the MASCC/ISOO mucositis clinical practice guidelines update. Support Care Cancer 2013;21:303-8
5. Gibson RJ, Cummins AG, Bowen JM,et al. Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asia Pac J Clin Oncol 2006;2:39-49
6. Blijlevens NM, Donnelly JP, De Pauw BE. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 2000;25:1269-78
7. Stringer AM, Al-Dasooqi N, Bowen JM,et al. Potential biomarkers of chemotherapy-induced diarrhea: a clinical study of intestinal microbiome alterations; intestinal inflammation and circulating matrix metalloproteinases. Support Care Cancer 2013;21:1843-52
8. Stringer AM, Gibson RJ, Bowen JM,et al. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 2009;90:489-99
9. Stringer AM, Gibson RJ, Logan RM,et al. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol 2009;64:123-32
10. Elting LS, Cooksley C, Chambers M,et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-9
11. Gibson RJ, Keefe DM, Lalla RV,et al. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 2013;21:313-26
12. Somerfield MR, Padberg J, Pfister DG. ASCO clinical practice guidelines: process, progress, pitfalls and prospects. Classic Papers Curr Comments 2000;4:5
13. Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 1996;49:749-54
14. Andrews M, Gallagher-Allred C. The role of zinc in wound healing. Adv Wound Care 1999;12:137-8
15. Maitra AK, Dorani B. Role of zinc in post-injury wound healing. Arch Emerg Med 1992;9:122-4
16. Thompson C, Fuhrman MP. Nutrients and wound healing: still searching for the magic bullet. Nutr Clin Pract 2005;20:331-47
17. Al-Dasooqi N, Sonis ST, Bowen JM,et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer 2013;21(11):3233-41
18. Mehdipour M, Taghavi Zenoz A, Asvadi Kermani I, Hosseinpour A. A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru 2011;19:71-3
19. Arbabi-kalati F, Deghatipour M, Ansari Moghadam A. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med 2012;15:413-17
20. Jensen SB, Pedersen AM, Vissink A,et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18:1061-79
21. Mansouri A, Hadjibabaie M, Iravani M,et al. The effect of zinc sulfate in the prevention of high-dose chemotherapyinduced mucositis: a double-blind, randomized, placebo-controlled study. Hematol Oncol 2012;30:22-6
22. Raber-Durlacher JE, von Bultzingslowen I, Logan RM,et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 2013;21:343-55.
23. Vadhan-Raj S, Trent J, Patel S,et al. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med 2010;153:358-67
24. Goldberg JD, Zheng J, Castro-Malaspina H,et al. Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2013;48:99-104
25. Blijlevens N, de Chateau M, Krivan G,et al. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patients burden. Bone Marrow Transplant 2013;48:966-71
26. Osterlund P, Ruotsalainen T, Korpela R,et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 2007;97:1028-34
27. Abd El-Atti S, Wasicek K, Mark S, Hegazi R. Use of probiotics in the management of chemotherapy-induced diarrhea: a case study. JPEN J Parenter Enteral Nutr 2009;33:569-70
28. Stringer AM, Gibson RJ, Bowen JM,et al. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 2009;90:489-99
29. Stringer AM, Gibson RJ, Logan RM,et al. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp Biol Med (Maywood) 2007;232:96-106
30. Bowen JM, Stringer AM, Gibson RJ,et al. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 2007;6:1449-54
31. Prisciandaro LD, Geier MS, Butler RN,et al. Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis. Crit Rev Food Sci Nutr 2011;51:239-47
32. Prisciandaro LD, Geier MS, Butler RN,et al. Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats. Cancer Biol Ther 2011;11:671-7
33. Wang H, Brook CL, Whittaker AL,et al. Effects of Streptococcus thermophilus TH-4 in a rat model of doxorubicin-induced mucositis. Scand J Gastroenterol 2013;48:959-68
34. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-33
35. Shanahan F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001;120:622-35
36. Holmberg J, Genander M, Halford MM,et al. EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 2006;125:1151-63
37. Kim KA, Kakitani M, Zhao J,et al. Mitogenic influence of human Rspondin1 on the intestinal epithelium. Science 2005;309:1256-9
38. Abraham C, Cho JH. Inducing intestinal growth. N Engl J Med 2005;353:2297-9
39. Bhanja P, Saha S, Kabarriti R,et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One 2009;4:e8014
40. Zhao J, Kim KA, De Vera J,et al. R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway. Proc Natl Acad Sci USA 2009;106:2331-6
41. Zhou WJ, Geng ZH, Spence JR, Geng JG. Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. Nature 2013;501:107-11.
42. Laskowitz DT, Lei B, Dawson HN,et al. The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage. Neurocrit Care 2012;16:316-26
43. Laskowitz DT, McKenna SE, Song P,et al. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J Neurotrauma 2007;24:1093-107
44. Wang H, Durham L, Dawson H,et al. An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimers disease pathology following closed head injury: evidence of pharmacogenomic interaction. Neuroscience 2007;144:1324-33
45. Azevedo OG, Oliveira RA, Oliveira BC,et al. Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis. BMC Gastroenterol 2012;12:35
46. Hausmann M, Obermeier F, Schreiter K,et al. Cathepsin D is up-regulated in inflammatory bowel disease macrophages. Clin Exp Immunol 2004;136:157-67
47. Menzel K, Hausmann M, Obermeier F,et al. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. Clin Exp Immunol 2006;146:169-80
48. Leblond J, Le Pessot F, Hubert-Buron A,et al. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood) 2008;233:219-28
49. Alamir I, Boukhettala N, Aziz M,et al. Beneficial effects of cathepsin inhibition to prevent chemotherapy-induced intestinal mucositis. Clin Exp Immunol 2010;162:298-305
50. Molan PC. Potential of honey in the treatment of wounds and burns. Am J Clin Dermatol 2001;2:13-19
51. Rashad UM, Al-Gezawy SM, El-Gezawy E, Azzaz AN. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol 2009;123:223-8
52. Abdulrhman M, El Barbary NS, Ahmed Amin D, Saeid Ebrahim R. Honey and a mixture of honey, beeswax, and olive oil-propolis extract in treatment of chemotherapy-induced oral mucositis: a randomized controlled pilot study. Pediatr Hematol Oncol 2012;29:285-92
53. Hawley P, Hovan A, McGahan CE, Saunders D. A randomized placebocontrolled trial of manuka honey for radiation-induced oral mucositis. Support Care Cancer 2013, doi:10.1007/s00520-0136-2031-0
54. Whitehouse MW, Turner AG, Davis CK, Roberts MS. Emu oil(s): a source of non-toxic transdermal antiinflammatory agents in aboriginal medicine. Inflammopharmacology 1998;6:1-8
55. Lindsay RJ, Geier MS, Yazbeck R,et al. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. Br J Nutr 2010;104:513-19
56. Mashtoub S, Tran CD, Howarth GS. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Exp Biol Med (Maywood) 2013;238(11):1305-17